Biomarkers as a diagnostic tool in primary and secondary dengue Infections
Abstract
Introduction: Dengue virus infection presents with a diverse clinical picture ranging from asymptomatic illness to Dengue fever to dengue hemorrhagic fever/dengue shock syndrome. Because of its varied clinical presentation, accurate diagnosis is difficult and relies largely on laboratory confirmation. We therefore designed a prospective study to ascertain the role of biomarkers in cases of serologically confirmed primary and secondary dengue infections.
Material & Methods: A total of 2165 patients presenting to the hospital with acute febrile illness were serologically confirmed to be suffering from dengue infection. Hematological examinationand Liver function test were carried out for all these cases.
Results: A total of 1942 (89.69%) patients were classified as having primary dengue infection and only 182(8.4%)were classified as having secondary dengue infection out of the total seropositive cases (2165).13.16% of these patients had platelet count below 50,000/mm3. Majority of the patients showed deranged hepatic function. Amongst the hepatic biomarkers AST and GGT were found to be significantly deranged as compared to other parameters.Also it was found that Alkaline phosphatase levels &platelet count may serve as early predictors for the differentiation of primary and secondary dengue infection.
Conclusion: The study highlights the importance of biochemical markers in distinguishing dengue from other febrile illness and their role in differentiating primary and secondary dengue cases.
Downloads
References
2. Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16. doi: 10.1038/nrmicro2460.[pubmed]
3. Linares EM, Pannuti CS, Kubota LT, et al. Immunospot assay based on fluorescent nanoparticles for Dengue fever detection. Biosens Bioelectron. 2013 Mar 15;41:180-5. doi: 10.1016/j.bios.2012.08.005. Epub 2012 Aug 16.[pubmed]
4. Hasan S, Jamdar SF, Alalowi M3, et al. Dengue virus: A global human threat: Review of literature. J Int Soc Prev Community Dent. 2016 Jan-Feb;6(1):1-6. doi: 10.4103/2231-0762.175416.[pubmed]
5. Wong M, Shen E. The utility of liver function tests in dengue. Ann Acad Med Singapore. 2008 Jan;37(1):82-3.[pubmed]
6. Parkash O, Almas A, Jafri SM, et al. Severity of acute hepatitis and its outcome in patients with dengue fever in a tertiary care hospital Karachi, Pakistan (South Asia). BMC Gastroenterol. 2010 May 7;10:43. doi: 10.1186/1471-230X-10-43.[pubmed]
7. World Health Organization, Special Programme for Research, Training in Tropical Diseases, World Health Organization. Department of Control of Neglected Tropical Diseases, World Health Organization.Epidemic, Pandemic Alert. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization; 2009.
8. Messina JP, Brady OJ, Pigott DM, et al. The many projected futures of dengue. Nat Rev Microbiol. 2015 Apr;13(4):230-9. doi: 10.1038/nrmicro3430. Epub 2015 Mar 2.[pubmed]
9. Malavige GN, Ranatunga PK, Jayaratne SD, et al. Dengue viral infections as a cause of encephalopathy. Indian J Med Microbiol. 2007 Apr;25(2):143-5.[pubmed]
10. Trung DT, Thao le TT, Hien TT, et al. Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg. 2010 Oct;83(4):774-80. doi: 10.4269/ajtmh.2010.10-0090.[pubmed]
11. Jayaratne SD, Atukorale V, Gomes L, et al. Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infection. BMC Res Notes. 2012 Nov 20;5:645. doi: 10.1186/1756-0500-5-645.[pubmed]
12. Ahmed NH, Broor S. Dengue fever outbreak in Delhi, North India: a clinico-epidemiological study. Indian journal of community medicine: official publication of Indian Association of Preventive & Social Medicine. 2015 Apr;40(2):135.[pubmed]
13. Ozer J, Ratner M, Shaw M, et al. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008 Mar 20;245(3):194-205. doi: 10.1016/j.tox.2007.11.021. Epub 2007 Dec 5.[pubmed]
14. Bandaru AK, Vanumu CS. Early predictors to differentiate primary from secondary dengue infection in children.Medical Journal of Dr. DY Patil University. 2016 Sep 1;9(5):587.
15. Fernando S, Wijewickrama A, Gomes L, et al. Patterns and causes of liver involvement in acute dengue infection. BMC Infect Dis. 2016 Jul 8;16:319. doi: 10.1186/s12879-016-1656-2.[pubmed]
16. Kuo CH, Tai DI, Chang-Chien CS, et al. Liver biochemical tests and dengue fever. Am J Trop Med Hyg. 1992 Sep;47(3):265-70.[pubmed]
17. Samanta J, Sharma V. Dengue and its effects on liver. World J Clin Cases. 2015 Feb 16;3(2):125-31. doi: 10.12998/wjcc.v3.i2.125.[pubmed]
18. Saha AK, Maitra S, HazraSCh. Spectrum of hepatic dysfunction in 2012 dengue epidemic in Kolkata, West Bengal. Indian J Gastroenterol. 2013 Nov;32(6):400-3. doi: 10.1007/s12664-013-0382-6. Epub 2013 Sep 14.[pubmed]
19. Itha S, Kashyap R, Krishnani N, et al. Profile of liver involvement in dengue virus infection. Natl Med J India. 2005 May-Jun;18(3):127-30.[pubmed]
20. Wahid SF, Sanusi S, Zawawi MM, et al. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health. 2000 Jun;31(2):259-63.[pubmed]
OAI - Open Archives Initiative
